Exhaled nitric oxide: A test for diagnosis and control of asthma?

Current Allergy and Asthma Reports

Volumn 7, Issue 6, 2007, Pages 459-463

  Katial, Rohit ^a   Stewart, Lora ^b  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FLUTICASONE; GLUCOCORTICOID; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; SHORT ACTING DRUG;

AIRFLOW; ASTHMA; BREATH ANALYSIS; CLINICAL TRIAL; CYTOTOXICITY; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG DOSE REDUCTION; EOSINOPHILIA; EPITHELIUM CELL; EXPIRATORY FLOW RATE; FORCED EXPIRATORY VOLUME; HUMAN; MACROPHAGE; MAST CELL; METERED DOSE INHALER; NERVE CELL; NEUTROPHIL; NON INVASIVE MEASUREMENT; NORMAL VALUE; PATIENT COMPLIANCE; REVIEW; SPIROMETRY; VASCULAR ENDOTHELIUM;

ADRENAL CORTEX HORMONES; ANTI-ASTHMATIC AGENTS; ASTHMA; BIOLOGICAL MARKERS; BREATH TESTS; EOSINOPHILS; HUMANS; NITRIC OXIDE; REFERENCE VALUES;

EID: 35448953010     PISSN: 15297322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11882-007-0070-7     Document Type: Review

References (49)

1. Palmer RM, Ferrige AG, Moncada S: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987, 327:524-526.
2. Gustafsson LE, Leone AM, Persson MG, et al.: Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans. Biochem Biophys Res Commun 1991, 181:852-857.
3. Alving K, Weitzberg E, Lundberg JM: Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J 1993, 6:1368-1370.
4. Kharitonov SA, Yates D, Robbins RA, et al.: Increased nitric oxide in exhaled air of asthmatic patients. Lancet 1994, 343:133-135.
5. Persson MG, Zetterstrom O, Agrenius V, et al.: Single-breath nitric oxide measurements in asthmatic patients and smokers. Lancet 1994, 343:146-147.
6. Yates DH, Kharitonov SA, Robbins RA, et al.: Effect of a nitric oxide synthase inhibitor and a glucocorticosteroid on exhaled nitric oxide. Am J Respir Crit Care Med 1995, 152:892-896.
7. Kharitonov SA, Yates DH, Barnes PJ: Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. Am J Respir Crit Care Med 1996, 153:454-457.
8. Massaro AF, Gaston B, Kita D, et al.: Expired nitric oxide levels during treatment of acute asthma. Am J Respir Crit Care Med 1995, 152:800-803.
9. Ricciardolo FL: Multiple roles of nitric oxide in the airways. Thorax 2003, 58:175-182.
10. Yates DH: Role of exhaled nitric oxide in asthma. Immunol Cell Biol 2001, 79:178-190.
11. Bates CA, Silkoff PE: Exhaled nitric oxide in asthma: from bench to bedside. J Allergy Clin Immunol 2003, 111:256-262.
12. Silkoff PE, McClean PA, Slutsky AS, et al.: Marked flow-dependence of exhaled nitric oxide using a new technique to exclude nasal nitric oxide. Am J Respir Crit Care Med 1997, 155:260-267.
13. Silkoff PE, Sylvester JT, Zamel N, Permutt S: Airway nitric oxide diffusion in asthma: Role in pulmonary function and bronchial responsiveness. Am J Respir Crit Care Med 2000, 161:1218-1228.
14. ATS/ERS Recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide. Am J Respir Crit Care Med 2005, 171:912-930.
15. George SC, Hogman M, Permutt S, Silkoff PE: Modeling pulmonary nitric oxide exchange. J Appl Physiol 2004, 96:831-839.
16. Tsoukias NM, George SC: A two-compartment model of pulmonary nitric oxide exchange dynamics [see comment]. J Appl Physiol 1998, 85:653-666.
17. Paraskakis E, Brindicci C, Fleming L, et al.: Measurement of bronchial and alveolar nitric oxide production in normal children and children with asthma. Am J Respir Crit Care Med 2006, 174:260-267.
18. Lehtimaki L, Kankaanranta H, Saarelainen S, et al.: Extended exhaled NO measurement differentiates between alveolar and bronchial inflammation. Am J Respir Crit Care Med 2001, 163:1557-1561.
19. Franklin PJ, Taplin R, Stick SM: A community study of exhaled nitric oxide in healthy children. Am J Respir Crit Care Med 1999, 159:69-73.
20. Kissoon N, Duckworth LJ, Blake KV, et al.: Exhaled nitric oxide concentrations: online versus offline values in healthy children. Pediatr Pulmonol 2002, 33:283-292.
21. Tsang KW, Ip SK, Leung R, et al.: Exhaled nitric oxide: the effects of age, gender and body size. Lung 2001, 179:83-91.
22. Chambers DC, Tunnicliffe WS, Ayres JG: Acute inhalation of cigarette smoke increases lower respiratory tract nitric oxide concentrations. Thorax 1998, 53:677-679.
23. Horvath I, Donnelly LE, Kiss A, et al.: Exhaled nitric oxide and hydrogen peroxide concentrations in asthmatic smokers. Respiration 2004, 71:463-468.
24. Berlyne GS, Parameswaran K, Kamada D, et al.: A comparison of exhaled nitric oxide and induced sputum as markers of airway inflammation. J Allergy Clin Immunol 2000, 106:638-644.
25. Jatakanon A, Lim S, Kharitonov SA, et al.: Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax 1998, 53:91-95.
26. Warke TJ, Fitch PS, Brown V, et al.: Exhaled nitric oxide correlates with airway eosinophils in childhood asthma. Thorax 2002, 57:383-387.
27. Brightling CE, Symon FA, Birring SS, et al.: Comparison of airway immunopathology of eosinophilic bronchitis and asthma. Thorax 2003, 58:528-532.
28. Payne DN, Adcock IM, Wilson NM, et al.: Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone [see comment]. Am J Respir Crit Care Med 2001, 164:1376-1381.
29. van den Toorn LM, Overbeek SE, de Jongste JC, et al.: Airway inflammation is present during clinical remission of atopic asthma. Am J Respir Crit Care Med 2001, 164:2107-2113. [Published erratum appears in Am J Respir Crit Care Med 2002, 166:1143.]
30. Silkoff PE, Lent AM, Busacker AA, et al.: Exhaled nitric oxide identifies the persistent eosinophilic phenotype in severe refractory asthma. J Allergy Clin Immunol 2005, 116:1249-1255.
31. Sont JK, Han J, van Krieken JM, et al.: Relationship between the inflammatory infiltrate in bronchial biopsy specimens and clinical severity of asthma in patients treated with inhaled steroids. Thorax 1996, 51:496-502.
32. Dupont LJ, Demedts MG, Verleden GM: Prospective evaluation of the validity of exhaled nitric oxide for the diagnosis of asthma. Chest 2003, 123:751-756.
33. Smith AD, Cowan JO, Filsell S, et al.: Diagnosing asthma: comparisons between exhaled nitric oxide measurements and conventional tests. Am J Respir Crit Care Med 2004, 169:473-478.
34. Smith AD, Taylor DR: Is exhaled nitric oxide measurement a useful clinical test in asthma? Curr Opin Allergy Clin Immunol 2005, 5:49-56.
35. Zietkowski Z, Bodzenta-Lukaszyk A, Tomasiak MM, et al.: Comparison of exhaled nitric oxide measurement with conventional tests in steroid-naive asthma patients. J Investig Allergol Clin Immunol 2006, 16:239-246.
36. Delgado-Corcoran C, Kissoon N, Murphy SP, Duckworth LJ: Exhaled nitric oxide reflects asthma severity and asthma control. Pediatr Crit Care Med 2004, 5:48-52.
37. Jatakanon A, Lim S, Barnes PJ: Changes in sputum eosinophils predict loss of asthma control. Am J Respir Crit Care Med 2000, 161:64-72.
38. Sont JK, Willems LN, Bel EH, et al.: Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. Am J Respir Crit Care Med 1999, 159:1043-1051.
39. Green RH, Brightling CE, Woltmann G, et al.: Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids. Thorax 2002, 57:875-879.
40. Meyts I, Proesmans M, De Boeck K: Exhaled nitric oxide corresponds with office evaluation of asthma control. Pediatr Pulmonol 2003, 36:283-289.
41. Smith AD, Cowan JO, Brassett KP, et al.: Use of exhaled nitric oxide measurements to guide treatment in chronic asthma [see comment]. N Engl J Med 2005, 352:2163-2173.
42. Little SA, Chalmers GW, MacLeod KJ, et al.: Non-invasive markers of airway inflammation as predictors of oral steroid responsiveness in asthma. Thorax 2000, 55:232-234.
43. Smith AD, Cowan JO, Brassett KP, et al.: Exhaled nitric oxide: a predictor of steroid response. Am J Respir Crit Care Med 2005, 172:453-459.
44. Szefler SJ, Phillips BR, Martinez FD, et al.: Characterization of within-subject responses to fluticasone and montelukast in childhood asthma [see comment]. J Allergy Clin Immunol 2005, 115:233-242.
45. Pijnenburg MW, Bakker EM, Hop WC, De Jongste JC: Titrating steroids on exhaled nitric oxide in children with asthma: a randomized controlled trial. Am J Respir Crit Care Med 2005, 172:831-836.
46. Katsara M, Donnelly D, Iqbal S, et al.: Relationship between exhaled nitric oxide levels and compliance with inhaled corticosteroids in asthmatic children. Respir Med 2006, 100:1512-1517.
47. Olivieri M, Talamini G, Corradi M, et al.: Reference values for exhaled nitric oxide (reveno) study. Respir Res 2006, 7:94.
48. Olin AC, Alving K, Torch K: Exhaled nitric oxide: relation to sensitization and respiratory symptoms. Clin Exp Allergy 2004, 34:221-226.
49. Buchvald F, Baraldi E, Carraro S, et al.: Measurements of exhaled nitric oxide in healthy subjects age 4 to 17 years. J Allergy Clin Immunol 2005, 115:1130-1136.